Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

Starbucks is looking to reignite consumer interest by teaming up with Disney for a limited-edition Minnie Mouse-themed ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Los Angeles County has declared a public health emergency as toxic smoke, dust and fumes from burning buildings threaten ...

Eli Lilly has said it is prepared to invest £279 ... noting that "widening waistbands are a burden on Britain." Lilly's Zepbound has become the first drug approved by the FDA for obese patients ...

January 10 has been named ‘Quitters Day’ because it is the day in which most people have given up on their new year’s ...

In its second R&D alliance this week, Eli Lilly has formed a partnership with Genetic Leap, a startup that focuses on applying artificial intelligence to the discovery of RNA-targeted therapies.

leadership skills and extensive experience across the interior Eli Cox is a four-year starter at center and right guard with most time spent at the former including 12 starts in 2024 inside ...

Supreme Court Seems Poised to Uphold Law That Could Ban TikTok The justices are expected to rule quickly in the case, which pits national security concerns about China against free speech ...